Inspire Medical Systems Hits New 52-Week Low at $48.78

Inspire Medical Systems, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 48.78 as of March 27, 2026. This significant decline marks a stark contrast to the company's 52-week high of USD 164.02, reflecting a challenging year for the stock, which has seen a performance drop of 68.86% over the past year. The company's market capitalization stands at USD 1,683 million, and it currently has a price-to-earnings (P/E) ratio of 11.00. Notably, Inspire Medical Systems does not offer a dividend, and its debt-to-equity ratio is reported at -0.39, indicating a unique financial structure. The return on equity is a robust 19.13%, and the price-to-book ratio is 2.15. As the stock navigates this low point, it highlights the volatility and challenges faced within the industry, particularly in the context of broader market performance, where the S&P 500 has gained 11.87% over the same period.